Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Eur J Med Res ; 27(1): 165, 2022 Aug 31.
Article in English | MEDLINE | ID: covidwho-2021339

ABSTRACT

PURPOSE: To report ischemic and haemorrhagic abdominal complications in a series of COVID-19 patients. To correlate these complications with lung involvement, laboratory tests, comorbidities, and anticoagulant treatment. METHODS: We retrospectively included 30 COVID-19 patients who undergone abdomen CECT for abdominal pain, between March 16 and May 19, 2020. Ischemic and haemorrhagic complications were compared with lung involvement (early, progressive, peak or absorption stage), blood coagulation values, anticoagulant therapy, comorbidities, and presence of pulmonary embolism (PE). RESULTS: Ischemic complications were documented in 10 patients (7 receiving anticoagulant therapy, 70%): 6/10 small bowel ischemia (1 concomitant obstruction, 1 perforation) and 4/10 ischemic colitis. Main mesenteric vessels were patent except for 1 superior mesenteric vein thrombosis. Two ischemia cases also presented splenic infarctions. Bleeding complications were found in 20 patients (all receiving anticoagulant treatments), half with active bleeding: hematomas in soft tissues (15) and retroperitoneum (2) and gastro-intestinal bleeding (3). Platelet and lymphocyte were within the normal range. D-Dimer was significantly higher in ischemic cases (p < 0.001). Most of the patients had severe lung disease (45% peak, 29% absorption), two patients PE. CONCLUSIONS: Ischemic and haemorrhagic abdominal complications may occur in COVID-19 patients, particularly associated to extended lung disease. CT plays a key role in the diagnosis of these potentially life- threatening conditions.


Subject(s)
COVID-19 , Pulmonary Embolism , Abdomen/diagnostic imaging , Anticoagulants/adverse effects , COVID-19/complications , Humans , Ischemia/chemically induced , Retrospective Studies
3.
Br J Radiol ; 94(1124): 20201220, 2021 Aug 01.
Article in English | MEDLINE | ID: covidwho-1309942

ABSTRACT

OBJECTIVES: With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. METHODS: A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. RESULTS: 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging findings in patients with COVID-19, majority described imaging abnormalities of the GI tract (16 studies), of which bowel wall thickening was most frequently reported. Other findings noted were abdominal imaging manifestations of bowel ischemia with thrombosis of the splanchnic vasculature, and imaging features suggestive of pancreatitis. Imaging findings suggestive of solid organ infarction were reported in nine studies. An association between imaging evidence of hepatic steatosis and COVID-19 was noted in three studies. Incidental lung base findings on abdominal imaging were noted in 18 studies, where patients presented with predominant GI symptoms. The most common finding was bilateral ground glass opacities (90.7%) with predominant multilobar (91.1%) and peripheral (64.4%) distribution. CONCLUSION: This systematic review provides insight into the abdominal imaging findings in patients with COVID-19. Knowledge of these imaging manifestations will not only help in further research but also will aid in curtailing transmission of the SARS-CoV-2. Further prospective studies are needed to gain better insight into the pathophysiology of these imaging manifestations. ADVANCES IN KNOWLEDGE: This review highlights the abdominal imaging findings in patients with COVID-19, to gain insight into the disease pathophysiology and gear the abdominal radiologist through the pandemic.


Subject(s)
Abdomen/diagnostic imaging , COVID-19/complications , Gastrointestinal Diseases/diagnostic imaging , Gastrointestinal Diseases/etiology , Humans
4.
Abdom Radiol (NY) ; 46(7): 3490-3500, 2021 07.
Article in English | MEDLINE | ID: covidwho-1265491

ABSTRACT

PURPOSE: To assess the spectrum of computed tomography angiogram (CTA) abdominal and pelvic findings in critically ill COVID-19 patients and investigate correlation with CT chest scores. METHODS: An IRB approved retrospective study of CTA of the chest, abdomen and pelvis between dates March 1st to September 15th, 2020 was performed in the hospitalized COVID-19 positive patients. CTA studies of solely the chest were excluded. Medical record review was performed to note patient demographics, CTA scan details and coagulation profile. CTA findings were reviewed to record vascular and non-vascular findings. CT chest was reviewed to calculate CT chest score. Logistic regression analyses were performed to correlate CT chest scores with odds of vascular and other abdomen-pelvis findings. A p < 0.05 was considered statistically significant. RESULTS: A total of 45 consecutive hospitalized COVID-19 positive patients with 61 years mean age and M:F (2:1) gender ratio were evaluated, out of which majority 68.9% (n = 31) had CTA chest, abdomen and pelvis. The most common vascular findings were hematoma 46.7% (n = 21), active extravasation 24.4% (n = 11) and vascular occlusion 17.8% (n = 8). Higher CT chest scores were significantly associated with hematoma/extravasation (OR 1.19, 95% CI 1.07-1.34, p < 0.01). The most common non-vascular abdomen-pelvis findings were seen in organs gallbladder 20% (n = 9), liver 20% (n = 9) followed by kidney 15.6% (n = 7). Higher CT chest scores were significantly associated with bowel findings (OR 1.28, 95% CI 1.01-1.63, p < 0.05) and cholestasis (OR 13.3, 95% CI 1.28-138.9, p < 0.05). CONCLUSION: Patients with moderate to severe COVID-19 pneumonia have significantly higher rate of vascular complications in the abdomen and pelvis.


Subject(s)
COVID-19 , Abdomen/diagnostic imaging , Computed Tomography Angiography , Critical Illness , Humans , Pelvis/diagnostic imaging , Retrospective Studies , SARS-CoV-2 , Tomography, X-Ray Computed
5.
Am J Emerg Med ; 49: 52-57, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1244700

ABSTRACT

PURPOSE: During the COVID-19 pandemic, emergency department (ED) volumes have fluctuated. We hypothesized that natural language processing (NLP) models could quantify changes in detection of acute abdominal pathology (acute appendicitis (AA), acute diverticulitis (AD), or bowel obstruction (BO)) on CT reports. METHODS: This retrospective study included 22,182 radiology reports from CT abdomen/pelvis studies performed at an urban ED between January 1, 2018 to August 14, 2020. Using a subset of 2448 manually annotated reports, we trained random forest NLP models to classify the presence of AA, AD, and BO in report impressions. Performance was assessed using 5-fold cross validation. The NLP classifiers were then applied to all reports. RESULTS: The NLP classifiers for AA, AD, and BO demonstrated cross-validation classification accuracies between 0.97 and 0.99 and F1-scores between 0.86 and 0.91. When applied to all CT reports, the estimated numbers of AA, AD, and BO cases decreased 43-57% in April 2020 (first regional peak of COVID-19 cases) compared to 2018-2019. However, the number of abdominal pathologies detected rebounded in May-July 2020, with increases above historical averages for AD. The proportions of CT studies with these pathologies did not significantly increase during the pandemic period. CONCLUSION: Dramatic decreases in numbers of acute abdominal pathologies detected by ED CT studies were observed early on during the COVID-19 pandemic, though these numbers rapidly rebounded. The proportions of CT cases with these pathologies did not increase, which suggests patients deferred care during the first pandemic peak. NLP can help automatically track findings in ED radiology reporting.


Subject(s)
Appendicitis/diagnostic imaging , Diverticulitis/diagnostic imaging , Emergency Service, Hospital , Intestinal Obstruction/diagnostic imaging , Tomography, X-Ray Computed/statistics & numerical data , Abdomen/diagnostic imaging , COVID-19/epidemiology , Humans , Massachusetts/epidemiology , Natural Language Processing , Retrospective Studies , SARS-CoV-2 , Utilization Review
6.
J Infect Dev Ctries ; 15(4): 530-537, 2021 04 30.
Article in English | MEDLINE | ID: covidwho-1218638

ABSTRACT

INTRODUCTION: Typhoid fever remains a problem in developing countries, including Pakistan. The emergence of multidrug-resistant and, since 2016, of extensively drug-resistant cases is a continuous challenge for health care workers. The COVID-19 pandemic is making management more difficult. METHODOLOGY: In the present study, a total of 52 confirmed cases of typhoid have been studied during 2019. Detailed clinical features, complications and, lab findings were studied. Typhoid culture and sensitivity were recorded and patients were treated accordingly. Patients were asked about risk factors to aim at informing prevention. RESULTS: Out of the 52 having blood culture positive for Salmonella Typhi 47 (90.4%) and Salmonella Paratyphi 5 (9.6%), 4 (7.7%) were sensitive to first-line (Non-resistant), 11 (21.2%) MDR and 37 (71.2%) patient were XDR. One case was resistant to azithromycin. Nausea, vomiting or, abdominal pain was present in 12 (23%), abdominal distension present in 9 (17.3%), abdominal tenderness in 8 (15.4%), hepatomegaly in 10 (19.2%) and, splenomegaly in 22 (42.3%).There were ultrasound abnormalities in 58% of patients and GI complications in 19% of patients. No significant difference was found in clinical findings and complications between resistant and non-resistant cases. Only 23-27% of patients were aware of typhoid prevention and vaccination measures. CONCLUSIONS: The increasing prevalence of resistance and higher degree of complications seen in typhoid fever raises the concern further about prevention and effective infection management in the community as well as clinical settings. Moreover, judicial use of antibiotics is much needed in developing countries like Pakistan.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Typhoid Fever/drug therapy , Typhoid Fever/etiology , Abdomen/diagnostic imaging , Adult , Cross-Sectional Studies , Drug Resistance, Multiple, Bacterial/drug effects , Female , Humans , Male , Pakistan , Salmonella paratyphi A/drug effects , Salmonella typhi/drug effects , Typhoid Fever/diagnostic imaging
7.
J Comput Assist Tomogr ; 45(3): 352-358, 2021.
Article in English | MEDLINE | ID: covidwho-1165588

ABSTRACT

ABSTRACT: The COVID-19 pandemic presents an ongoing global health threat. The SARS-CoV-2 is known to cause substantial pulmonary disease, and most of the current radiological publications are dedicated to describing and characterizing these findings. However, studies regarding imaging findings in the abdomen and pelvis of infected patients are still very limited. The aim of this review is to discuss the most frequent abdominal manifestations based on the current literature and representative images from our local experience.


Subject(s)
Abdomen/diagnostic imaging , COVID-19/complications , Pelvis/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Abdomen/virology , COVID-19/diagnostic imaging , Female , Humans , Male , Multidetector Computed Tomography/methods , Pelvis/virology
8.
Malawi Med J ; 32(4): 192-196, 2020 12.
Article in English | MEDLINE | ID: covidwho-1079762

ABSTRACT

Background: We describe the incidental detection of patients infiltrates due to COVID-19 in lung basal sections in patients undergoing abdominal computed tomography (CT) with flank pain attending the urology outpatient clinic during the current pandemic. Methods: We retrospectively analysed 276 patients admitted to the Siirt Training and Research Hospital Urology outpatients clinic between 15 March 2020 and 9 August 2020 with a complaint of flank pain and undergoing non-contrast abdominal CT. A total of 10 patients with COVID-19 compatible findings in CT were defined as the study group. A control group was formed from 10 patients with only urological pathologies (kidney stones, ureteral stones, and hydronephrosis) without a COVID-19 compatible appearance on CT. Results: Ten (3.6 %) patients were identified with COVID-19 and pneumonic infiltrations in the basal regions of the lungs; diagnosis was made by cross-sectional abdominal CT. The visual analog scale (VAS) score of flank pain was significantly higher in the control group (p<0.001); these subjects had urological pathology and no evidence of COVID-19 in the basal regions of the lungs on abdominal CT. There were no signs of COVID-19 disease detected during the admissions procedure in the urology outpatient clinic, including fever, cough, and shortness of breath. Conclusion: During the COVID-19 pandemic, it is important to consider a diagnosis of COVID_19 in patients reporting non-severe flank pain if no urological pathology is evident on abdominal CT scans.


Subject(s)
Abdomen/diagnostic imaging , COVID-19/diagnosis , Flank Pain/etiology , Lung/diagnostic imaging , SARS-CoV-2/isolation & purification , Adult , COVID-19 Nucleic Acid Testing , Cohort Studies , Humans , Incidental Findings , Male , Middle Aged , Pandemics , SARS-CoV-2/genetics , Tomography, X-Ray Computed/methods
9.
Pediatr Infect Dis J ; 40(2): e82-e83, 2021 02 01.
Article in English | MEDLINE | ID: covidwho-968321

ABSTRACT

We report findings on abdominal imaging in critically ill children admitted with MIS-C. On sonography, hepatomegaly, nephromegaly, gallbladder wall edema, ascites, intestinal inflammation and mesenteric lymphadenopathy were seen, while CT showed fluid-filled small bowel loops, mural thickening of the terminal ileum, diffuse lymphadenopathy, and moderate ascites.


Subject(s)
Abdomen/diagnostic imaging , COVID-19/diagnostic imaging , Inflammation/diagnostic imaging , Adolescent , Ascites/diagnostic imaging , COVID-19/physiopathology , COVID-19/therapy , Child , Child, Preschool , Critical Illness , Female , Gallbladder Diseases/diagnostic imaging , Hepatomegaly/diagnostic imaging , Humans , Ileum/diagnostic imaging , Infant , Inflammation/drug therapy , Inflammation/physiopathology , Intestine, Small/diagnostic imaging , Kidney Diseases/diagnostic imaging , Lymphadenopathy/diagnostic imaging , Male , Mesenteric Lymphadenitis/diagnostic imaging , Mucocutaneous Lymph Node Syndrome/diagnostic imaging , SARS-CoV-2 , Ultrasonography
10.
J Korean Med Sci ; 35(43): e391, 2020 Nov 09.
Article in English | MEDLINE | ID: covidwho-918115

ABSTRACT

Since mid-April 2020, cases of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 that mimics Kawasaki disease (KD) have been reported in Europe and North America. However, no cases have been reported in Korea. We describe an 11-year old boy with fever, abdominal pain, and diarrhea who developed hypotension requiring inotropes in intensive care unit. His blood test revealed elevated inflammatory markers, thrombocytopenia, hypoalbuminemia, and coagulopathy. Afterward, he developed signs of KD such as conjunctival injection, strawberry tongue, cracked lip, and coronary artery dilatation, and parenchymal consolidation without respiratory symptoms. Microbiological tests were all negative including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain reaction. However, serum immunoglobulin G against SARS-CoV-2 was positive in repeated tests using enzyme-linked immunosorbent assay and fluorescent immunoassay. He was recovered well after intravenous immunoglobulin administration and discharged without complication on hospital day 13. We report the first Korean child who met all the criteria of MIS-C with features of incomplete KD or KD shock syndrome.


Subject(s)
Coronavirus Infections/pathology , Pneumonia, Viral/pathology , Systemic Inflammatory Response Syndrome/diagnosis , Abdomen/diagnostic imaging , Antibodies, Viral/blood , Betacoronavirus/genetics , Betacoronavirus/immunology , COVID-19 , Child , Coronavirus Infections/complications , Coronavirus Infections/virology , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Mucocutaneous Lymph Node Syndrome/pathology , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/virology , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/complications , Thorax/diagnostic imaging , Tomography, X-Ray Computed , Ultrasonography
11.
Korean J Gastroenterol ; 76(3): 164-166, 2020 09 25.
Article in English | MEDLINE | ID: covidwho-793520

ABSTRACT

The World Health Organization has declared novel coronavirus disease 2019 (COVID-19) a global public health emergency. Although respiratory symptoms predominate in COVID-19, thrombosis can occur in patients with COVID-19. This paper reports a case of an 82-year-old female with a prior medical history of hypertension, diabetes presenting with fever and cough, and was diagnosed with COVID-19. The patient subsequently developed progressively worsening of abdominal distention, tenderness, and underwent emergent laparotomy. She was found to have a gangrenous colon. This case adds to the limited literature regarding the extrapulmonary complications of COVID-19.


Subject(s)
Colitis/diagnosis , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Venous Thrombosis/diagnosis , Abdomen/diagnostic imaging , Abdomen/surgery , Acute Disease , Aged, 80 and over , Anticoagulants/therapeutic use , Betacoronavirus/isolation & purification , COVID-19 , Colitis/pathology , Coronavirus Infections/complications , Coronavirus Infections/virology , Female , Heparin/therapeutic use , Humans , Laparotomy , Necrosis , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/virology , SARS-CoV-2 , Tomography, X-Ray Computed , Venous Thrombosis/complications , Venous Thrombosis/drug therapy
12.
Abdom Radiol (NY) ; 46(3): 1256-1262, 2021 03.
Article in English | MEDLINE | ID: covidwho-777751

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the frequency, indications, and findings of abdominal CTs ordered in the initial evaluation of patients who had a positive COVID-19 test performed in our institution. METHODS: Retrospective chart review was performed on all patients who had a positive test for COVID-19 performed at a single quaternary care center from 1/20/2020 through 5/8/2020. In a subset of patients undergoing abdominal CT as part of the initial evaluation, the demographics, suspected COVID-19 status at the time of scan, presenting complaints, and abdominal CT findings were recorded. Cardiothoracic radiologists reviewed and scored the visualized lung bases for the likelihood of COVID-19. RESULTS: Only 43 (4.1%) of 1057 COVID-19 patients presented with abdominal complaints sufficient to warrant an abdominal CT. Of these 43 patients, the vast majority (39, 91%) were known or suspected to have COVID-19 at the time of the scan. Most (27/43, 63%) scans showed no acute abdominal abnormality, and those that were positive did not share a discernable pattern of abnormalities. Lung base abnormalities were common, and there was moderate inter-reviewer reliability. CONCLUSION: A minority of COVID-19 patients present with abdominal complaints sufficient to warrant a dedicated CT of the abdomen, and most of these studies will be negative or have abdominal findings not associated with COVID-19. Appropriate lung base findings are a more consistent indication of COVID-19 infection than abdominal findings.


Subject(s)
COVID-19/epidemiology , Gastrointestinal Diseases/diagnostic imaging , Gastrointestinal Diseases/epidemiology , Tomography, X-Ray Computed/methods , Abdomen/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Comorbidity , Female , Humans , Incidence , Male , Middle Aged , Reproducibility of Results , Retrospective Studies , SARS-CoV-2 , Young Adult
13.
Abdom Radiol (NY) ; 46(3): 1249-1255, 2021 03.
Article in English | MEDLINE | ID: covidwho-756310

ABSTRACT

PURPOSE: This scoping review evaluated the currently available data related to abdominal imaging in the SARS-CoV-2 infection. METHOD: A systematic review of MEDLINE, EMBASE, SCOPUS, and Web of Science was performed from inception to July 15, 2020 using PRISMA-ScR guidelines. The review included case reports and series discussing radiologic manifestations of SARS-CoV-2 infection in abdominal imaging studies. Studies published from inception to March 31, 2020, were independently screened and reviewed by one author, and another author reviewed studies published after March 31 to July 15, 2020. Study screening and full-text review for publications before March 31, 2020, was performed by one author, and another author for publications after March 31 to July 15, 2020. RESULTS: Thirty-six studies were included in qualitative synthesis. The prevalence of gastrointestinal symptoms is roughly 18% and includes loss of appetite, nausea, vomiting, diarrhea, and abdominal pain. Sixteen percent of COVID-19 cases may only present with gastrointestinal symptoms. Many patients presenting this way demonstrate evidence of COVID-19 incidentally through abdominal CT imaging at the lung bases. Studies published to date have also reported abdominal imaging findings including small and large bowel wall thickening, fluid-filled colon, pneumatosis intestinalis, pneumoperitoneum, intussusception, and ascites. CONCLUSION: Gastrointestinal manifestations and imaging manifestations of SARS-CoV-2 infection are increasingly reported and warrant specific attention during abdominal imaging.


Subject(s)
COVID-19/complications , Diagnostic Imaging/methods , Gastrointestinal Diseases/complications , Gastrointestinal Diseases/diagnostic imaging , Abdomen/diagnostic imaging , Humans , SARS-CoV-2
14.
Radiology ; 297(1): E207-E215, 2020 10.
Article in English | MEDLINE | ID: covidwho-243264

ABSTRACT

Background Angiotensin-converting enzyme 2, a target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), demonstrates its highest surface expression in the lung, small bowel, and vasculature, suggesting abdominal viscera may be susceptible to injury. Purpose To report abdominal imaging findings in patients with coronavirus disease 2019. Materials and Methods In this retrospective cross-sectional study, patients consecutively admitted to a single quaternary care center from March 27 to April 10, 2020, who tested positive for SARS-CoV-2 were included. Abdominal imaging studies performed in these patients were reviewed, and salient findings were recorded. Medical records were reviewed for clinical data. Univariable analysis and logistic regression were performed. Results A total of 412 patients (average age, 57 years; range, 18 to >90 years; 241 men, 171 women) were evaluated. A total of 224 abdominal imaging studies were performed (radiography, n = 137; US, n = 44; CT, n = 42; MRI, n = 1) in 134 patients (33%). Abdominal imaging was associated with age (odds ratio [OR], 1.03 per year of increase; P = .001) and intensive care unit (ICU) admission (OR, 17.3; P < .001). Bowel-wall abnormalities were seen on 31% of CT images (13 of 42) and were associated with ICU admission (OR, 15.5; P = .01). Bowel findings included pneumatosis or portal venous gas, seen on 20% of CT images obtained in patients in the ICU (four of 20). Surgical correlation (n = 4) revealed unusual yellow discoloration of the bowel (n = 3) and bowel infarction (n = 2). Pathologic findings revealed ischemic enteritis with patchy necrosis and fibrin thrombi in arterioles (n = 2). Right upper quadrant US examinations were mostly performed because of liver laboratory findings (87%, 32 of 37), and 54% (20 of 37) revealed a dilated sludge-filled gallbladder, suggestive of bile stasis. Patients with a cholecystostomy tube placed (n = 4) had negative bacterial cultures. Conclusion Bowel abnormalities and gallbladder bile stasis were common findings on abdominal images of patients with coronavirus disease 2019. Patients who underwent laparotomy often had ischemia, possibly due to small-vessel thrombosis. © RSNA, 2020.


Subject(s)
Abdomen/diagnostic imaging , Coronavirus Infections/diagnostic imaging , Gastrointestinal Diseases/diagnostic imaging , Gastrointestinal Diseases/virology , Pneumonia, Viral/diagnostic imaging , Abdomen/pathology , Abdomen/surgery , Abdomen/virology , Adolescent , Adult , Aged , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/pathology , Female , Gastrointestinal Diseases/pathology , Gastrointestinal Diseases/surgery , Humans , Laparotomy , Male , Middle Aged , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/pathology , Retrospective Studies , SARS-CoV-2 , Young Adult
17.
Clin Hemorheol Microcirc ; 74(4): 353-361, 2020.
Article in English | MEDLINE | ID: covidwho-116593

ABSTRACT

In the hands of experienced examiners, the contrast enhanced sonography (CEUS) offers the possibility to analyze dynamic microcirculatory disturbances in real time dynamically without any risk for kidneys and thyroid gland even in severe progressing disease bedside. Based on severe COVID-19 infections, first experiences with abdominal CEUS examinations are presented. In the stage of an imminent organ failure with significantly reduced kidney and liver function, CEUS can be used to show a narrowing of the organ-supplying arteries, as well as a delayed capillary filling of vessels near the capsule, a regional reduced parenchymal perfusion or an inflammatory hyperemia with capillary hypercirculation. It is possible to quickly rule out organ infarction and to dynamically record the mesenteric arterial and venous blood flow.


Subject(s)
Abdomen/blood supply , Coronavirus Infections/diagnostic imaging , Microcirculation , Pneumonia, Viral/diagnostic imaging , Vascular Diseases/diagnostic imaging , Abdomen/diagnostic imaging , Aged , Betacoronavirus , COVID-19 , Contrast Media/chemistry , Female , Humans , Inflammation/diagnostic imaging , Kidney/diagnostic imaging , Liver/diagnostic imaging , Male , Middle Aged , Pandemics , Perfusion , Risk , SARS-CoV-2 , Thyroid Gland/diagnostic imaging , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL